Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'hiv resistance'
hiv resistance published presentations and documents on DocSlides.
DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
by olivia-moreira
Isaguliants. Maria. Department of Microbiology, ...
HIV-1 pol diversity and drug resistance mutations among female bar and hotel workers in Northern T
by danika-pritchard
Ireen Kiwelu. Kilimanjaro International PhD sympo...
ARV Resistance 1 Learning Objectives
by naomi
Define drug resistance. Identify . factors that in...
Management of NRTI Resistance
by giovanna-bartolotta
David Spach, MD. Principal . Investigator, NW AET...
Track B Workshop Controversies in the Management of HIV-positive Adults:
by natalia-silvester
A Case-Based Approach. Sasisopin Kiertiburanakul,...
Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah
by debby-jeon
HIV Drug Resistance (HIVDR) and Antimicrobial Res...
Public Health Surveillance of Transmitted Antiretroviral Resistance, Oregon 2007 – 2011
by tatiana-dople
Sean Schafer MD. May 31, 2012. Three Studies in O...
HIV Drug Resistance in Well-Resourced Settings
by faustina-dinatale
Vincent Marconi, . MD. Outline. Transmitted Drug ...
Figure Figure. Kinetics of viremia, CD4+ T-cell count, and drug resistance mutations in a
by amber
Bansal V, Metzner KJ, Niederöst B, Leemann C, Bö...
ICASA Track
by tatiana-dople
A – Basic Science. Rapporteur’s Report. GROUP...
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...
Workshop on ART in Pregnancy, Breastfeeding, and Beyond
by celsa-spraggs
Johannesburg, South Africa. June 18-20, 2012. HIV...
New drugs for individuals
by Ziggystardust
with multi-resistant virus. 6 APRIL 2020. Faculty....
HIV-1 drug resistance and third-line outcomes among children and adolescents
by lydia
failing second-line therapy . in Malawi. Rachel Ka...
HIV and viral hepatitis co-infection
by cheryl-pisano
Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...
Advances and Challenges in HIV Antiretroviral Therapy
by stefany-barnette
Camille Angle, Meagan Bardan, Hanna Schimjawicz a...
Multi Drug Resistant Tuberculosis (MDR-TB) Among HIV-Positive Patients in A Tertiary Health Instit
by olivia-moreira
Akujobi. CN, . Okoro. CE, . Anyabolu. AE, . O...
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
Mechanisms of HIV-1 Resistance to ADCC
by isla
David Evans. University of Wisconsin-Madison. July...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
INITIAL MANAGEMENT OF THE PATIENT LIVING WITH HIV
by edolie
PART 3. INITIATING THERAPY. Objectives. After comp...
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Virologic and Immunologic Monitoring in HIV Care
by sylvia
and. HIV Resistance Assays. www.hivguidelines.org....
Jacob S Iramiot Welcome remarks from chair Conference –Dr
by giovanna-bartolotta
Mpagi. . Welcomed participants to conference an...
Young person with multi-class resistance: follow-up and man
by luanne-stotts
(with perspectives from well-resourced and resour...
Jacob S Iramiot Welcome remarks from chair Conference –Dr
by myesha-ticknor
Mpagi. . Welcomed participants to conference an...
Chlamydia and Gonorrhea breakout session
by jovita
Connie L. . Celum. , MD, MPH. Professor of Global ...
Drug susceptibility testing and mortality in patients treated for
by priscilla
tuberculosis in high-burden countries. Kathrin . Z...
Multidrug resistant tuberculous
by lydia
meningitis in the United States, 1993-2005. Presen...
Stephanie Cox Gilead Sciences
by emery
Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...
Joseph J. Eron Jr, MD
by lois-ondreau
Joseph J. Eron Jr, MD Professor of Medicine Unive...
HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional
by mitsue-stanley
HBV Clinical Management [TRAINER(S) NAME(S)] IAPA...
Darwin’s Surprise Why are evolutionary biologists bringing back extinct deadly viruses?
by kittie-lecroy
Michael Specter. The New Yorker. December 3, 2007...
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
Why study evolution? Best conceptual framework for understanding
by tatyana-admore
. origins of biodiversity . Adaptations that all...
Genomic epidemiology of extensively drug-resistant tubercul
by kittie-lecroy
Demographic expansion and genetic determinants of...
Treatment of Children and Adolescents
by liane-varnes
Implementation Challenges. Annette H. Sohn, MD. T...
Direct Observations of Evolutionary Change
by faustina-dinatale
Two examples provide evidence for natural selecti...
Highlights of AIDS
by calandra-battersby
2016: Advances in . HIV Prevention, Care and Trea...
Load More...
![HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional](https://thumbs.docslides.com/761285/hbv-clinical-management-trainer-s-name-s-iapac-african-regional.jpg)
